CytomX Therapeutics
CTMX
CTMX
142 hedge funds and large institutions have $739M invested in CytomX Therapeutics in 2018 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 62 increasing their positions, 44 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
8% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 24
1% more funds holding
Funds holding: 141 → 142 (+1)
12% less capital invested
Capital invested by funds: $843M → $739M (-$104M)
Holders
142
Holding in Top 10
4
Calls
$2.74M
Puts
$1.2M
Top Buyers
| 1 | +$16.4M | |
| 2 | +$14.9M | |
| 3 | +$12.8M | |
| 4 |
Renaissance Technologies
New York
|
+$10.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$8.62M |
Top Sellers
| 1 | -$29M | |
| 2 | -$7.54M | |
| 3 | -$7.54M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$6.56M |
| 5 |
PC
PointState Capital
New York
|
-$4.38M |